Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer (CFO) and Treasurer, effective September 25, 2023.…
The Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, today announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for…
ReAlta Life Sciences, Inc. è un’azienda di biotech clinical-stage impegnata nell’usare la potenza del sistema immunitario per contrastare e risolvere situazioni come malattie rare e malattie infiammatorie acute potenzialmente letali.…
Rapid Medical™, a leading developer of advanced neurovascular devices, announced Chinese approval of its TIGERTRIEVER revascularization device. With this milestone approval from the National Medical Products Administration (NMPA), TIGERTRIEVER becomes the first device to…
Longaevus Technologies, announces the spin-off of Elastin Biosciences following breakthrough preclinical results of 3 of its assets. Longaevus Technologies is a company builder with dedicated to longevity, with an all-round…
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Reblozyl® (luspatercept-aamt) for the treatment of anemia without previous erythropoiesis stimulating agent use (ESA-naïve) in adult…
LIB Therapeutics Inc., a clinical-stage biopharmaceutical company developing subcutaneous and oral PCSK9 inhibitor medicines for patients at very high and high risk of cardiovascular disease (“CVD”) requiring additional reductions in…
The Foundation for the National Institutes of Health (FNIH) has awarded its sixth annual Trailblazer Prize for Clinician-Scientists to Vinod Balachandran, M.D., at Memorial Sloan Kettering Cancer Center (MSK), for his…
eClinicalWorks®, the largest ambulatory cloud EHR, today announced that Global Open Wound Care—a mobile wound care clinic specializing in advanced wound treatments and point-of-care treatment decision-making—has selected eClinicalWorks EHR to enhance…
Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage biotechnology company developing novel tumor necrosis factor superfamily receptor (TNFSR) antagonist antibodies, announced today that the Food and Drug Administration…
Immunis, Inc., a private biotech and a leading innovator in cellular secretome therapies for age and disease-related immune decline, is honored to be selected as a finalist for the “Best Emerging…
CAS is the American Chemical Society’s specialized division for scientific information solutions and Molecule.one is the Leading company in biotechnology. The two institutions have entered into a strategic collaboration focused on…